From: Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma
Drug
Dose (mg/kg/day)
Schedule
TVI%a (day 49)
SAHA
100
qdx5/w x4w
42
ST0001
60
2qdx5/w x4w
14
SAHA + ST0001
66*